| $8M | ||
| $7M | ||
| $6M | ||
| $6M | ||
| $5M | ||
| $3M |
Buys | $16,742,985 | 1 | 100 |
Sells | $0 | 0 | 0 |
| JONAS HOWARD S | Exec Chairman, CEO & President | 1 | $16.74M | 0 | $0 | $16.74M |
Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company's lead drug candidate is CPI-613 (devimistat), which is being evaluated in various clinical studies, including two Phase III registrational clinical trials for the treatment of metastatic pancreatic cancer and r/r acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
Over the last 12 months, insiders at Rafael Holdings, Inc. have bought $16.74M and sold $0 worth of Rafael Holdings, Inc. stock.
On average, over the past 5 years, insiders at Rafael Holdings, Inc. have bought $12.95M and sold $449,542 worth of stock each year.
Highest buying activity among insiders over the last 12 months: JONAS HOWARD S (Exec Chairman, CEO & President) — $16.74M.
The last purchase of 13,080,457 shares for transaction amount of $16.74M was made by JONAS HOWARD S (Exec Chairman, CEO & President) on 2025‑06‑05.
| 2025-06-05 | JONAS HOWARD S | Exec Chairman, CEO & President | 13.08M 20.7622% | $1.28 | $16.74M | -9.94% | ||
| 2022-08-09 | Sale | JONAS HOWARD S | Executive Chairman | 64,674 0.284% | $1.84 | $118,948 | +10.44% | |
| 2022-08-08 | Sale | JONAS HOWARD S | Executive Chairman | 14,787 0.0639% | $1.94 | $28,678 | +3.08% | |
| 2022-08-05 | Sale | JONAS HOWARD S | Executive Chairman | 97,774 0.4119% | $1.87 | $182,967 | +4.15% | |
| 2022-08-05 | Sale | i9 PLUS, LLC | 64,674 0.2678% | $1.84 | $118,948 | +4.15% | ||
| 2022-07-06 | JONAS HOWARD S | Executive Chairman | 6.45M 31.6178% | $1.86 | $12M | +4.17% | ||
| 2021-08-24 | JONAS HOWARD S | Chief Executive Officer | 225,122 1.3289% | $44.92 | $10.11M | -91.70% |
| JONAS HOWARD S | Exec Chairman, CEO & President | 12299207 35.047% | $15.13M | 3 | 3 | +4.17% |
| i9 PLUS, LLC | 3225806 9.1921% | $3.97M | 0 | 1 |
$400,335 | 5 | 3.01% | $101.32M | |
$5,986,165 | 5 | -18.81% | $5.2B | |
$1,099,966 | 1 | 5.06% | $28.82B | |
$1,000,000 | 1 | 7.56% | $5.6M |
| Increased Positions | 24 | +50% | 749,051 | +18.99% |
| Decreased Positions | 16 | -33.33% | 434,321 | -11.01% |
| New Positions | 8 | New | 145,040 | New |
| Sold Out Positions | 6 | Sold Out | 169,652 | Sold Out |
| Total Postitions | 56 | +16.67% | 4M | +7.98% |
| Vanguard Group Inc | $1,646.00 | 2.74% | 1.39M | +133,024 | +10.54% | 2025-09-30 |
| Ieq Capital, Llc | $499.00 | 0.83% | 423,087 | +199,055 | +88.85% | 2025-09-30 |
| Geode Capital Management, Llc | $419.00 | 0.7% | 355,449 | -95,690 | -21.21% | 2025-09-30 |
| Blackrock, Inc. | $380.00 | 0.63% | 322,323 | -71,703 | -18.2% | 2025-09-30 |
| Dimensional Fund Advisors Lp | $352.00 | 0.59% | 298,227 | -38,899 | -11.54% | 2025-09-30 |
| Epiq Capital Group, Llc | $287.00 | 0.48% | 243,030 | -17,618 | -6.76% | 2024-12-31 |
| Founders Fund V Management, Llc | $200.00 | 0.33% | 169,451 | 0 | 0% | 2025-09-30 |
| Kahn Brothers Group Inc | $187.00 | 0.31% | 158,674 | -2,358 | -1.46% | 2025-09-30 |
| Wells Fargo & Company/Mn | $122.00 | 0.2% | 103,392 | +79,907 | +340.25% | 2025-09-30 |
| Northern Trust Corp | $100.00 | 0.17% | 84,476 | +23,786 | +39.19% | 2025-09-30 |